|
|
Jukka Takala, MD, PhD
Section Editor, Critical Care and Trauma
|
|
Jukka Takala, MD, PhD
Professor of Intensive Care Medicine
University Hospital of Bern
Bern, Switzerland CH-3010
Phone: 41.31.632.39.04
Languages: Finnish, English, German
E-mail: jukka.takala{at}insel.ch
|
|
Professional Interests: Although my early research in Finland focused on nutrition, I gradually became interested in other aspects of critical care. In the late 1980s, with a team of investigators at the Kuopio University Hospital, I began to study the interrelationships between splanchnic tissue perfusion and the pathophysiology of multiorgan dysfunction. That research continued when I moved to Bern, Switzerland, in 1999. As Chairman of the Department of Intensive Care Medicine at the University Hospital, I head both clinical and experimental research in critical care, focusing on pathophysiology of organ dysfunctions in critical care patients. In parallel, I have continued to pursue my interests in costs and quality, protocols for weaning and sedation, resource use, and the organization of intensive care.
| Current departmental research funding: Orion Pharmaceuticals, Edwards Lifesciences, Braun, Altana, and Pulsion. Current departmental consultancies/collaborations: Edwards Lifesciences, General Electric. Former departmental research funding: Instrumentarium/General Electric, Eli Lilly Former Departmental consultancies/collaborations: Eli Lilly. Personal honoraria: Edwards Lifesciences. Personal Advisory Board Memberships: Edwards Lifesciences Critical Care Europe. Personal consultancies: none. Former personal board memberships: Instrumentarium Corp. Board of Directors.
|
|
|
|
|
